<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors provide disease histories of 4 patients afflicted with genuine <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>There were 2 men and 2 women who developed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e> (ATM) at an age of 24 to 31 years </plain></SENT>
<SENT sid="2" pm="."><plain>Before ATM developed, SLE standing was from 3 to 10 years </plain></SENT>
<SENT sid="3" pm="."><plain>Based on the authors' and reported data, the problems of the pathogenesis, clinical picture, diagnosis and prognosis in that grave complication of SLE are discussed </plain></SENT>
<SENT sid="4" pm="."><plain>As for the mechanisms of ATM development, the role of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is reviewed </plain></SENT>
<SENT sid="5" pm="."><plain>The data on familial aggravation of the patients are presented in terms of the development of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in their relatives </plain></SENT>
<SENT sid="6" pm="."><plain>Emphasis is laid on the necessity of early intensive care with <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> hormones and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> of patients with associated SLE and ATM in order to improve their prognosis </plain></SENT>
</text></document>